EMCURE:NSE
Emcure Pharmaceuticals Ltd
₹ २,३४८.००
arrow_upward
+१.४५%(+३३.६०) 1D
नोभेम्बर १३, १५:३०:०० GMT+५:३० · INR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EMCURE...
Open
₹ २,३२५.००
High
₹ २,३९५.००
Low
₹ २,३१५.४०
Mkt. cap
४.४७ खरब
Avg. vol.
२.२९ लाख
Volume
२.९५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.२९
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
Open
₹ २,३२५.००
High
₹ २,३९५.००
Low
₹ २,३१५.४०
Mkt. cap
४.४७ खरब
Avg. vol.
२.२९ लाख
Volume
२.९५ लाख
Dividend
०.१५%
Quarterly dividend
₹ ०.९०
Ex-dividend date
२०२६ सेप्टेम्बर ४
P/E ratio
४९.२९
52-wk high
₹ २,४२९.९०
52-wk low
₹ १,३१२.३०
EPS
₹ ४७.६४
No. of employees
७ हजार
News stories
From web sources and news partners
Quantisnow
·
२ मिनेट पहिले
PowerCompute (Nasdaq: PWCM) Reports Third Quarter 2026 Results...
TradingView
·
१२ मिनेट पहिले
Goldman Sachs Reportedly Sees AI Hyperscalers As ‘Relatively Defensive’ After Tech Selloff — Forecasts 14% S&P 500 Upside
TheStreet
·
६ मिनेट पहिले
Stock Market Today (Nov. 13, 2026): Nasdaq futures fall after Nvidia CEO resigns
Reuters
·
३२ मिनेट पहिले
Nasdaq futures dip as Nvidia tumult keeps investors on edge
Profile
Emcure Pharmaceuticals Limited is an Indian multinational pharmaceutical company, headquartered in Pune. Emcure's product portfolio includes tablets, capsules and injectables. The company produces gynaecology, cardiovascular, oncology and blood therapeutic drugs, HIV antivirals and other anti-infectives, and vitamins and minerals. Wikipedia
About Emcure Pharmaceuticals Ltd
CEOSatish Ramanlal Mehta
Employees६.९१ हजार
Founded१९८१ अप्रिल १६
Headquarters-
SectorHealth Care
Industry-
Websiteemcure.com